Autres langues CSL Limited

Actions

CSL

AU000000CSL8

Produits pharmaceutiques

Marché Fermé - Australian S.E. 08:14:51 29/07/2026 Varia. 5j. Varia. 1 janv.
128,07 AUD +7,15% Graphique intraday de CSL Limited +8,59% -25,82%

Autres langues

09:06 Australia shares reclaim 9,000 mark; softer inflation cools hike bets
08:22 Australian Shares Advance; Rio Tinto Group Posts Higher H1 Underlying Earnings, Revenue
04:59 ASX Midday Sector Update: Healthcare Stocks Lead Broad-Based Rally
04:42 Australian shares extend gains after inflation undershoots forecasts
03:10 Australia shares reclaim 9,000 mark on Rio Tinto, CSL boost
02:55 CSL to start clinical trials for new immunoglobulin manufacturing process
02:54 CSL to Conduct Trial Work to Confirm Efficacy, Safety of Immunoglobulin Produced Via Proprietary Process; Shares Jump 6%
28/07 CSL Says Topline Phase 3b Results Support Plan to Seek Expanded Pediatric Indication for Andembry
27/07 Csl Reports Positive Top-Line Phase 3B Results Supporting Planned Expanded Pediatric Filing for Andembry in Children with Hereditary Angioedema
22/07 Daily Special: Altoro Metals, Carnegie Clean Energy, Mastermyne Group, Eden Innovations, Stelar Metals
22/07 ASX Midday Sector Update: Materials Stocks Jump, Healthcare Sector Struggles
21/07 Australian benchmark ends flat as investors stay cautious on Mideast woes
21/07 Daily Special: Streamplay Studio, Eagle Mountain Mining, Falcon Metals, Noumi, Riedel Resources
21/07 ASX Midday Sector Update: Information Technology Stocks Inch Up, Healthcare Sector Struggles
08/07 Sanofi to stop disparaging rival flu vaccine to stave off EU antitrust fine
03/07 Australian shares log best week in 3 as Fed-hike bets cool; banks, miners lead
01/07 ASX Midday Sector Update: Healthcare Stocks Advance, Consumer Staples Sector Struggles
30/06 BCG e Remo Stoffel non raggiungono un accordo
30/06 GKB und Remo Stoffel finden keine Einigung in Millionenklage
29/06 Australian shares gain on mining boost and easing US-Iran tensions
29/06 CSL Says CHMP Recommends Revocation of TAVNEOS Marketing Authorization in Europe
26/06 European Regulator Calls for Amgen's Tavneos to Have Authorization Revoked -- Update
26/06 CHMP recommends revoking marketing authorisation for TAVNEOS® (avacopan) in the European Union
25/06 US prices for new drugs fell in 2025 as fewer costly gene therapies were launched
25/06 CSL, Plasma Industry Could Continue to Grow Strongly for Considerable Period, Jefferies Says
Aucun résultat pour cette recherche